Latest Asx Filings News

Cazaly Resources has issued a replacement Appendix 5B for the March 2025 quarter to correct an administrative error, reaffirming a solid cash position with over six quarters of funding available.

Oncosil Medical Ltd has announced a significant 400-for-1 security consolidation affecting shares, options, and performance rights, with shareholder approval scheduled for late May 2025.

Ark Mines Ltd has successfully raised A$1.5 million through a fully subscribed placement, enabling a faster development of its rare earth project in North Queensland.

Pantoro Gold is set to become debt free by repaying its US$6.26 million Convertible Loan Facility ahead of schedule, reducing shareholder dilution and saving on interest payments.

Clean TeQ Water has landed a A$1.2 million engineering contract to design a DESALX® wastewater treatment plant for Nyrstar's European operations, paving the way for a potential A$9.4 million project stage.

Healius Limited has completed the $822 million cash sale of Lumus Imaging to Affinity Equity Partners, setting the stage for a strategic refocus on pathology and a substantial special dividend payout.

HitIQ Limited's trading suspension has been lifted following its announcement of a proposed capital raising, signaling renewed investor interest and potential growth opportunities.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

BluGlass has completed a $2.3 million placement and launched a $6 million Share Purchase Plan to fund scaling of its GaN laser production, targeting high-growth sectors including quantum sensing and defense.

Sparc Technologies has successfully raised up to A$2.7 million through a share placement and a Share Purchase Plan, positioning the company to accelerate commercialisation of its graphene additive ecosparc and support its green hydrogen pilot projects.

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

Nanoveu Limited has successfully raised $2.3 million through a share placement to accelerate development and commercialization of its cutting-edge semiconductor, 3D visualization, and solar coating technologies.